Completed PHASE1/PHASE2 INTERVENTIONAL NCT00004811

Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis

Sponsor: National Center for Research Resources (NCRR)

Conditions Blastomycosis Histoplasmosis Sporotrichosis

Updated 5 times since 2017 Last updated: Jun 8, 2006 Started: Mar 31, 1985

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00004811, this PHASE1/PHASE2 trial focuses on Blastomycosis and Histoplasmosis and remains completed. Sponsored by National Center for Research Resources (NCRR), it has been updated 5 times since 1985, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Mar 1985

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID)
University of Alabama at Birmingham

Data source: Office of Rare Diseases (ORD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.